You have 9 free searches left this month | for more free features.

savolitinib

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Male Subjects Trial in Brooklyn (Savolitinib, Fluvoxamine)

Not yet recruiting
  • Healthy Male Subjects
  • Brooklyn, Maryland
    Research Site
May 25, 2023

NSCLC Trial in Guangzhou (Savolitinib, Docetaxel)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Department of Thoracic Surgery and Oncology, The First Affiliate
Mar 17, 2023

Lung Cancer Trial (Savolitinib, Durvalumab)

Recruiting
  • Lung Cancer
  • Beijing, China
  • +2 more
Jan 11, 2023

Healthy Male Subjects Trial (Savolitinib, Digoxin, Metformin Hydrochloride)

Not yet recruiting
  • Healthy Male Subjects
  • Savolitinib
  • +4 more
  • (no location specified)
Mar 3, 2023

Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)

Recruiting
  • Stomach Cancer, Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 10, 2023

NSCLC Trial in Guangzhou (Savolitinib, Placebo)

Recruiting
  • Non-small Cell Lung Cancer
  • Savolitinib
  • Placebo
  • Guangzhou, China
    Guangdong General Hospital
Nov 29, 2021

NSCLC Trial in Guangzhou (Osimertinib, Savolitinib)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong General Hospital, Gua
Dec 6, 2021

Gastric Cancer, Esophagogastric Junction Disorder Trial in Beijing (Savolitinib)

Recruiting
  • Gastric Cancer
  • Esophagogastric Junction Disorder
  • Savolitinib
  • Beijing, Beijing, China
    Beijing Cancer Hopspital
Aug 30, 2021

Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

Active, not recruiting
  • Renal Clear Cell Carcinoma
  • Renal Papillary Cell Carcinoma
  • Savolitinib
  • +2 more
  • London, United Kingdom
    Thomas Powles
Aug 10, 2022

NSCLC Metastatic Trial in Shanghai (Savolitinib)

Recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Savolitinib
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Aug 30, 2021

Solid Tumors Trial in Baltimore (Savolitinib, Midazolam)

Completed
  • Solid Tumors
  • Baltimore, Maryland
    Research Site
Aug 18, 2021

NSCLC Trial in Marseille (Durvalumab (MEDI4736), Monalizumab (IPH2201), Oleclumab (MEDI9447))

Recruiting
  • Non-small Cell Lung Cancer
  • Durvalumab (MEDI4736)
  • +5 more
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Sep 21, 2022

Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

Active, not recruiting
  • Carcinoma
  • +7 more
  • La Jolla, California
  • +58 more
Jan 13, 2023

Lung Sarcomatoid Carcinoma Trial in Beijing, Shanghai (Savolitinib)

Active, not recruiting
  • Lung Sarcomatoid Carcinoma
  • Savolitinib
  • Beijing, Beijing, China
  • +1 more
Nov 29, 2021

Carcinoma Trial in Worldwide (osimertinib, savolitinib, )

Recruiting
  • Carcinoma
  • La Jolla, California
  • +95 more
Feb 1, 2023

Carcinoma, Non-Small-Cell Lung Trial in Worldwide (Savolitinib, Osimertinib, Pemetrexed)

Not yet recruiting
  • Carcinoma
  • Non-Small-Cell Lung
  • Savolitinib
  • +4 more
  • Orange City, Florida
  • +78 more
Jul 20, 2022

Solid Tumours Trial in Baltimore (Savolitinib, Famotidine)

Completed
  • Solid Tumours
  • Baltimore, Maryland
    Research Site
Jul 2, 2020

Solid Tumors Trial in Baltimore (Savolitinib, Rifampicin)

Completed
  • Solid Tumors
  • Baltimore, Maryland
    Research Site
Apr 2, 2020

Prostate Cancer Trial in Canada (Adavosertib, Savolitinib, Darolutamide)

Recruiting
  • Prostate Cancer
  • Edmonton, Alberta, Canada
  • +10 more
May 9, 2022

Solid Tumour Trial in Glendale (Savolitinib, Itraconazole)

Completed
  • Solid Tumour
  • Glendale, California
    Research Site
Jan 22, 2020

NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Avignon, France
  • +36 more
Jul 29, 2022

Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7

Active, not recruiting
  • Locally Advanced Papillary Renal Cell Carcinoma
  • +6 more
  • Cabozantinib S-malate
  • +3 more
  • Anchorage, Alaska
  • +596 more
Aug 2, 2022

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023